These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 1102803

  • 1. Inter-relationships between plasma angiotensin II, arterial pressure, aldosterone and exchangeable sodium in normotensive and hypertensive man.
    Beevers DG, Brown JJ, Cuesta V, Davies DL, Fraser R, Lebel M, Lever AF, Morton JJ, Oelkers W, Robertson JI, Schalekamp MA, Tree M.
    J Steroid Biochem; 1975 May; 6(5):779-84. PubMed ID: 1102803
    [No Abstract] [Full Text] [Related]

  • 2. Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretic.
    Weinberger MH, Dowdy AJ, Nokes GW, Luetscher JA.
    J Clin Endocrinol Metab; 1968 Mar; 28(3):359-71. PubMed ID: 5642688
    [No Abstract] [Full Text] [Related]

  • 3. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T, Doi K, Ogihara T, Ichihara K, Hata T, Kumahara Y.
    Prog Biochem Pharmacol; 1976 Mar; 12():174-89. PubMed ID: 1019163
    [Abstract] [Full Text] [Related]

  • 4. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
    Beyer J, Liebau G, Steiner B, Schick K, Hayduk K.
    Verh Dtsch Ges Kreislaufforsch; 1977 Mar; 43():212-3. PubMed ID: 613577
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB, Morton JJ, Brown JJ, Davies DL, Fraser R, Kelly P, Leckie B, Lever AF, Robertson JI.
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [Abstract] [Full Text] [Related]

  • 7. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Prog Biochem Pharmacol; 1976 Sep; 12():230-41. PubMed ID: 1019166
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Editorial: Sodium and the pressor role of angiotensin.
    Lancet; 1973 Nov 10; 2(7837):1065-6. PubMed ID: 4127318
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition?
    Davies DL, Beevers DG, Brown JJ, Cumming AM, Fraser R, Lever AF, Mason PA, Morton JJ, Robertson JI, Titterington M, Tree M.
    J Endocrinol; 1979 May 10; 81(2):79P-91P. PubMed ID: 458346
    [No Abstract] [Full Text] [Related]

  • 15. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.
    Laragh JH.
    Am J Med; 1973 Sep 10; 55(3):261-74. PubMed ID: 4355699
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.